Caldera Medical, Inc. – Trademark Portfolio
Entity Type: 03
Caldera Medical, Inc. holds 35 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 31 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 4 Nice Classification classes. Currently, 10 trademarks are registered and 7 are pending. Notable registered marks include DESARA, INNOVO, BENESTA, CALDERA, and TRELLIS. The owner is based in Agoura Hills, CA.
5171 Clareton Drive
Agoura Hills, CA 91301
Showing of trademarks Trademarks
Trademark Classifications
Caldera Medical, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Caldera Medical, Inc. have?
Caldera Medical, Inc. has 35 U.S. trademarks filed with the USPTO. Of these, 10 registered, 7 pending, 9 abandoned, 9 cancelled.
What trademark classes does Caldera Medical, Inc. file in?
Caldera Medical, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals), Class 25 (Clothing), Class 9 (Computers & Electronics). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Caldera Medical, Inc.'s most well-known trademarks?
Caldera Medical, Inc.'s registered trademark portfolio includes well-known marks such as DESARA, INNOVO, BENESTA, CALDERA, and TRELLIS. These are among 10 currently registered trademarks in the portfolio.
What is Caldera Medical, Inc.'s trademark registration success rate?
Caldera Medical, Inc. has a 36% trademark registration rate, with 10 out of 28 resolved applications resulting in successful registration. Currently, 7 applications are pending review.